![]() |
CiteULike | ![]() |
Group: Integrative Expertise for Gl... | ![]() |
![]() |
|
![]() |
Register | ![]() |
Log in | ![]() |

<<For members posting publications to the group here some guidelines on tag use - for more details, pls check the tags and the papers linked.
Tags will appear alphabetically, yet it is helpful for the community to use some specific clusters:>> -- the name of the disease or health-problem, where the group's focus is on health-problems with a high prevalence, particularly also in developing countries; -- the country where the health-care study was carried out; -- the "socio-technical" level of the health care actors studied: PICO, if these actors are individuals, such as patients, nurses, physicians; MICRO, if the actors addressed in the research are organizations such as health posts, hospitals, care-centers, educational centers, etc; MESO, if the research focuses on industry-specific institutions, e.g., for pharmaceutical industry, health insurance, methodologies for bridging know-do gaps, for ensuring strength of recommendatios,... MACRO, if the research focuses on the socio-technical/socio-economic landscape where multiple industries, sectors interact, or share common resources.e.g. such as Intellectual property rights, open access regimes, ICT infrastructures, health financing, etc; MULTI-LEVEL: when several levels are addressed. -- where in the regulative cycle (or in the path bridging the gap from knowledge to practice) is the focus: on problem-articulation, on diagnosis, on therapy - design, synthesis, test, on evaluation?
<<Pls suggest enhancements!>>
Posted by jago on 2008-11-30 21:08:08.
0 replies. Login or join this group to post to this thread.